glp-1 vs sglt2 weight loss Recommendations for SGLT2i versus RA on the basis of kidney SGLT2 vs GLP-1 for CKD:

Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis

Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks

Pick a ratio based on your target dose if your dose lands below 5 units on a U-100 syringe, use more water for easier reading

How these medications work Both medications mimic gut hormones that regulate hunger and blood sugar, but Mounjaro targets an additional pathway

There is currently no approved starting dose for patients because retatrutide has not yet been licensed for routine prescribing